PDB18 COST-EFFECTIVENESS OF ADD-ON PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) THERAPY IN DIABETIC VERSUS NON-DIABETIC PATIENTS WITH DYSLIPIDEMIA- A UK PERSPECTIVE
Abstract
Authors
B Paschen S Roze AJ Palmer WJ Valentine D Liens C Renaudin